Dr. Alberto Paniz-Mondolfi, MD, PhD

EDUCATION AND TRAINING

INSTITUTION/LOCATION	DEGREE	FIELD OF STUDY
La Salle College (La Colina)., Caracas, Venezuela.	BSc	Bachelor of Science
Universidad Central de Venezuela, José Maria	MD	Medicine and Surgery
Vargas School of Medicine., Caracas, Venezuela/Universitat de Valencia., Valencia, Spain	MSc	Parasitology and Tropical Disease
José Gregorio Hernández Medical Institute, Caracas, Venezuela	Intern Resident	Internal Medicine
St. Luke’s Hospital and Columbia Univ. College of Physicians and Surgeons, NY, NY	Resident	Anatomic and Clinical Pathology
Tufts University Medical Center., Boston, MA	Fellow	Dermatopathology
Baylor College of Medicine., Houston, TX	Fellow	Molecular Genetic Pathology
Yale University School of Medicine., New Haven, CT	Fellow	Medical Microbiology
Universidad de Los Andes., Mérida, Venezuela	PhD	Fundamental Medical Sciences

BIOGRAPHY

Dr. Paniz Mondolfi, a specialist in microbiology and tropical infectious diseases, currently serves as the Director of Molecular Microbiology at Mount Sinai Hospital and holds the position of Associate Professor at the Icahn School of Medicine at Mount Sinai. With roles spanning leadership in infectious disease divisions and pathology laboratories, his career is distinguished by significant contributions. His trajectory in the scientific domain has been marked by substantive contributions, significantly impacting the landscape of endemic and emerging infectious diseases.

Throughout his professional journey, Dr. Paniz Mondolfi has assumed pivotal roles, including Academic Director and Chief of the Division of Infectious Diseases and Tropical Medicine at the IDB Clinic in Barquisimeto, Venezuela. His leadership extends to being the head of the Infectious Disease Pathology Laboratory and coordinator of the Zoonosis and Emerging Pathogens Regional Collaborative Network at the Venezuelan Research Incubator. Previous positions encompassed serving as the head of the Infectious Disease Pathology Section at the Laboratory of Biochemistry and National coordinator for epidemiology and control of Leprosy and Leishmaniasis at the Institute of Biomedicine in Caracas, Venezuela.

In terms of education, Dr. Paniz Mondolfi acquired his medical degree from Universidad Central de Venezuela, his PhD from Universidad de Los Andes and undertook a research fellowship at the Institute of Biomedicine in Caracas. His residency training encompassed Internal Medicine at IVSS in Caracas, Venezuela, and Anatomic and Clinical Pathology at St. Luke’s-Roosevelt and Beth Israel Medical Center in New York City. Further academic pursuits led to a master’s degree in Parasitology from the University of Valencia (Spain) and advanced fellowship courses in Infectious Diseases at esteemed institutions globally.

A multifaceted professional, Dr. Paniz Mondolfi underwent training in Dermatopathology at Tufts University and Molecular Genetic Pathology at Baylor College of Medicine. His unwavering commitment to advancing medical knowledge prompted a Winchester fellowship in Medical Microbiology at Yale University School of Medicine.

Dr. Paniz Mondolfi’s research endeavors delve into the intricate aspects of eco-epidemiology and pathology concerning arthropod-borne viruses, protozoa, and trypanosomatid parasitic infections. His specialized focus on antimicrobial and antiprotozoal chemotherapy has catalyzed research into the identification and evaluation of novel drugs and formulations for treating leishmaniasis and American trypanosomiasis (Chagas disease). Remarkably, he served as an advisor for the US Department of Defense, contributing to the largest investigational trial evaluating the efficacy of trypanocidal drug combinations for T. cruzi infection in military working dogs.

Holder of a US-issued patent on the composition and method for treating Chagas Disease, Dr. Paniz Mondolfi continues to forge ahead in the scientific arena. His ongoing research interests span the development of avant-garde diagnostic methods and predictive models for disease ecology, spatial epidemiology, and molecular epidemiology of endemic and emerging infectious diseases. This includes his dedicated efforts in studying SARS-CoV-2 and the emergence of other viral diseases like Yellow Fever, South American Hemorrhagic fevers, Hantaviruses and arboviruses such as Zika, Mayaro, Dengue, and Chikungunya.

With an extensive academic portfolio boasting over 200 peer-reviewed manuscripts in globally esteemed journals such as the New England Journal of Medicine, the Lancet, and Science, Dr. Paniz Mondolfi emerges as a beacon in advancing our nuanced understanding of infectious diseases on a global scale.